Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MaaT-033 by MaaT Pharma for Axial Spondyloarthritis: Likelihood of Approval
MaaT-033 is under clinical development by MaaT Pharma and currently in Phase III for Axial Spondyloarthritis. According to GlobalData, Phase...
MaaT-033 by MaaT Pharma for Chemotherapy Effects: Likelihood of Approval
MaaT-033 is under clinical development by MaaT Pharma and currently in Phase I for Chemotherapy Effects. According to GlobalData, Phase...
MaaT-033 by MaaT Pharma for Chemotherapy Effects: Likelihood of Approval
MaaT-033 is under clinical development by MaaT Pharma and currently in Phase I for Chemotherapy Effects. According to GlobalData, Phase...
MaaT-033 by MaaT Pharma for Amyotrophic Lateral Sclerosis: Likelihood of Approval
MaaT-033 is under clinical development by MaaT Pharma and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData,...